FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 42291-489 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA213191
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (800 mg/1)
Marketing started20240925
Package count1

External sources

Source: openFDA. Public-domain (CC0).